Shingles Vaccine Market Competitive Scenario, Opportunities, Development Status 2028
Shingles Vaccine Industry Overview The global shingles vaccine market size is expected to reach USD 6.35 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.9% from 2021 to 2028. Increasing incidence of shingles and high awareness regarding shingles in developed countries are contributing to the market growth. According to the CDC, nearly one million cases of shingles are reported each year in the United States. Furthermore, one out of three individuals in the country will develop the disease in their lifetime. Shingles Vaccine Market Segmentation Grand View Research has segmented the global shingles vaccine market on the basis of product, vaccine type, and region: Based on the Product Insights, the market is segmented into Shingrix, Zostavax and SkyZoster. Shingrix held the largest share of more than 90.0% in 2020 owing to the high efficacy of the vaccine with no serious events associated with it. Moreover, ...